Retained products of conception
Updates to Article Attributes
Retained products of conception (RPOC) refersrefer to the persistence of placental and/or fetal tissue in the uterus following delivery, termination of pregnancy or a miscarriage.
Epidemiology
RPOC complicatesRetained products of conception complicate ~1% of all pregnancies. It occurs with greater frequency with:
- medical termination of pregnancy (MTP)
- second-trimester miscarriage
- placenta accreta
Clinical presentation
Common symptoms include vaginal bleeding and abdominal or pelvic pain, similar to patients with gestational trophoblastic disease.
Differentiation of these entities is important because retained products of conception isare treated conservatively or with curettage, while gestational trophoblastic disease may require chemotherapy.
ß-human chorionic gonadotropin (beta-hCG) remains elevated in patients with gestational trophoblastic disease but falls to an undetectable level over 2-3 weeks, in cases of retained products.
Radiographic features
Ultrasound
Ultrasound is typically the first-line investigation in suspected RPOCretained products of conception:
- variable amount of echogenic or heterogeneous material within the endometrial cavity
- presence of vascularity within the echogenic material supports the diagnosis but the absence of color Doppler flow has a low negative predictive value because
RPOCretained products of conception may be avascular 9 - calcifications may be present
RPOCRetained products of conception can be suspected on ultrasound if the endometrial thickness is >10 mm following dilatation and curettage or spontaneous abortion (80% sensitive).
MRI
Retained products of conception can appear on MR imaging as an intracavitary uterine soft-tissue mass with variable amounts of enhancing tissue and variable degrees of myometrial thinning and obliteration of the junctional zone.
Signal characteristics include:
- T1: variable heterogeneous signal 1
- T2: variable heterogeneous signal 1
- T1 C+ (Gd): can show variable enhancement
Differential diagnosis
For ultrasound appearances consider:
- blood clot within the endometrial cavity (often co-exists): non-vascular on colour Doppler ultrasound
- endometritis
- gestational trophoblastic disease
- uterine arteriovenous malformation (if prominent blood flow is present)
See also
-<p><strong>Retained products of conception (RPOC) </strong>refers to the persistence of placental and/or fetal tissue in the uterus following delivery, termination of pregnancy or a <a href="/articles/miscarriage">miscarriage</a>. </p><h4>Epidemiology</h4><p>RPOC complicates ~1% of all pregnancies. It occurs with greater frequency with:</p><ul>- +<p><strong>Retained products of conception </strong>refer to the persistence of placental and/or fetal tissue in the uterus following delivery, termination of pregnancy or a <a href="/articles/miscarriage">miscarriage</a>. </p><h4>Epidemiology</h4><p>Retained products of conception complicate ~1% of all pregnancies. It occurs with greater frequency with:</p><ul>
-</ul><h4>Clinical presentation</h4><p>Common symptoms include vaginal bleeding and abdominal or pelvic pain, similar to patients with <a href="/articles/gestational-trophoblastic-disease">gestational trophoblastic disease</a>. </p><p>Differentiation of these entities is important because retained products of conception is treated conservatively or with curettage, while gestational trophoblastic disease may require chemotherapy.</p><p>ß-human chorionic gonadotropin (<a href="/articles/beta-hcg-1">beta-hCG</a>) remains elevated in patients with gestational trophoblastic disease but falls to an undetectable level over 2-3 weeks, in cases of retained products.</p><h4>Radiographic features</h4><h5>Ultrasound</h5><p>Ultrasound is typically the first-line investigation in suspected RPOC:</p><ul>- +</ul><h4>Clinical presentation</h4><p>Common symptoms include vaginal bleeding and abdominal or pelvic pain, similar to patients with <a href="/articles/gestational-trophoblastic-disease">gestational trophoblastic disease</a>. </p><p>Differentiation of these entities is important because retained products of conception are treated conservatively or with curettage, while gestational trophoblastic disease may require chemotherapy.</p><p>ß-human chorionic gonadotropin (<a href="/articles/beta-hcg-1">beta-hCG</a>) remains elevated in patients with gestational trophoblastic disease but falls to an undetectable level over 2-3 weeks, in cases of retained products.</p><h4>Radiographic features</h4><h5>Ultrasound</h5><p>Ultrasound is typically the first-line investigation in suspected retained products of conception:</p><ul>
-<li>presence of vascularity within the echogenic material supports the diagnosis but the absence of color Doppler flow has a low negative predictive value because RPOC may be avascular <sup>9</sup>- +<li>presence of vascularity within the echogenic material supports the diagnosis but the absence of color Doppler flow has a low negative predictive value because retained products of conception may be avascular <sup>9</sup>
-</ul><p>RPOC can be suspected on ultrasound if the endometrial thickness is >10 mm following dilatation and curettage or spontaneous abortion (80% sensitive).</p><h5>MRI</h5><p>Retained products of conception can appear on MR imaging as an intracavitary uterine soft-tissue mass with variable amounts of enhancing tissue and variable degrees of myometrial thinning and obliteration of the junctional zone. </p><p>Signal characteristics include:</p><ul>- +</ul><p>Retained products of conception can be suspected on ultrasound if the endometrial thickness is >10 mm following dilatation and curettage or spontaneous abortion (80% sensitive).</p><h5>MRI</h5><p>Retained products of conception can appear on MR imaging as an intracavitary uterine soft-tissue mass with variable amounts of enhancing tissue and variable degrees of myometrial thinning and obliteration of the junctional zone. </p><p>Signal characteristics include:</p><ul>